Xiaowei Ma
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Antimicrobial Resistance in Staphylococcus 4
- SARS-CoV-2 detection and testing 4
-
- Prostate Cancer Treatment and Research 5
- Ferroptosis and cancer prognosis 5
- Co-authors
- Xing‐Jie Liang (3 shared papers)Yuliang Zhao (1 shared paper)Xiangdong Xue (1 shared paper)Keni Yang (1 shared paper)Shuaidong Huo (1 shared paper)Paul C. Wang (1 shared paper)Shubin Jin (1 shared paper)Zhongbo Hu (1 shared paper)
- Journals
- Scientific Reports (5 papers)Analytical Chemistry (3 papers)Stem Cell Research (2 papers)PLoS ONE (2 papers)Frontiers in Microbiology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaowei Ma
94 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 117
- Biomaterials 474
- Drug Discovery 4
- Pharmaceutical Science 99
- Complementary and alternative medicine 97
- Immunology 194
Countries citing papers authored by Xiaowei Ma
This map shows the geographic impact of Xiaowei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowei Ma more than expected).
Fields of papers citing papers by Xiaowei Ma
This network shows the impact of papers produced by Xiaowei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowei Ma. The network helps show where Xiaowei Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaowei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 400 | |
| 2 | 2011 | 265 | |
| 3 | 2018 | 244 | |
| 4 | 2016 | 191 | |
| 5 | 2019 | 133 | |
| 6 | 2024 | 76 | |
| 7 | 2010 | 75 | |
| 8 | 2011 | 64 | |
| 9 | 2024 | 55 | |
| 10 | 2013 | 53 | |
| 11 | 2016 | 50 | |
| 12 | 2014 | 48 | |
| 13 | 2004 | 46 | |
| 14 | 2015 | 45 | |
| 15 | 2013 | 41 | |
| 16 | 2016 | 41 | |
| 17 | 2018 | 41 | |
| 18 | 2023 | 41 | |
| 19 | 2021 | 39 | |
| 20 | 2003 | 36 |
About Xiaowei Ma
Xiaowei Ma is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Complementary and alternative medicine, Molecular Biology and Neurology, having authored 102 papers that have together received 2.8k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (8 papers), Alzheimer's disease research and treatments (5 papers), Prostate Cancer Treatment and Research (5 papers), Ferroptosis and cancer prognosis (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Advanced Radiotherapy Techniques (4 papers), SARS-CoV-2 detection and testing (4 papers) and Advanced Drug Delivery Systems (3 papers). The work is most often cited by research in Biomaterials (474 citations), Drug Discovery (4 citations), Pharmaceutical Science (99 citations), Complementary and alternative medicine (97 citations) and Immunology (194 citations). Xiaowei Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xing‐Jie Liang, Yuliang Zhao, Xiangdong Xue, Keni Yang, Shuaidong Huo, Paul C. Wang, Shubin Jin, Zhongbo Hu, Jinchao Zhang and Anil Kumar. Their work appears in journals such as Scientific Reports, Analytical Chemistry, Stem Cell Research, PLoS ONE and Frontiers in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.